FDA Approves BUPIVACAINE HYDROCHLORIDE — Anthea Pharma Private Limited

# FDA Approves Anthea Pharma's Generic Bupivacaine Hydrochloride for Epidural Use Anthea Pharma Private Limited received FDA approval for its generic bupivacaine hydrochloride epidural formulation (ANDA220493), entering a competitive market for this widely-used local anesthetic and potentially capturing significant share from branded alternatives and existing generics in pain management procedures. The approval expands treatment options for healthcare providers while likely exerting downward pricing pressure in the epidural anesthetic segment.